Human Bioequivalence Study of Amphotericin B Liposome for Injection

NCT06977490 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Invasive Fungal Infections
Neutropenic Fever
Visceral Leishmaniasis

Interventions

DRUG: Amphotericin B Liposome for Injection (strength: 50 mg, Sichuan Huiyu Pharmaceutical Co., Ltd.)
DRUG: Amphotericin B Liposome for Injection (trade name: Ambisome®, strength: 50 mg, MAH: Gilead Sciences)

Sponsor

Sichuan Huiyu Pharmaceutical Co., Ltd

Collaborators

Changsha King-eagle Med Technology Co., Ltd.